Amyotrophic lateral sclerosis (ALS) is probably one of the most devastating diagnoses that we should all hope to never hear. Also known as Lou Gehrig's disease, or motor neuron disease, ALS is a prog ...
The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...
ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is ...
ALS is a debilitating paralytic disease characterized by the death of upper and lower motor neurons. Fortunately, ALS is ...
Clinical Trials Arena on MSN
FDA grants clearance to Prilenia and Ferrer’s Phase III ALS therapy trial
The study will be carried out at up to 60 ALS treatment centres across Canada, the EU, the US, Israel and the UK.
In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...
Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...
MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic ...
A Massachusetts woman wanted to leave the world laughing. Linda Murphy’s humorous and heartfelt obituary went viral after she died at 60 years old following a three-year battle with Bulbar ALS. “Well, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback